Composition:
Each tablet of Lapatinib 250 mg contains 250 mg of Lapatinib as the active ingredient.
Description:
HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy. Lapatinib is used in combination with other medication Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients.
Lapatinib 250 mg is mainly prescribed for the treatment of:
Share your experience with our medical product. Write a review!
05 Feb 2026
Food Habits That Increase Diabetes Risk - And How Fenugreek Can Help Manage Blood Sugar Naturally
Diet plays a crucial role in the development and management of type 2 diabetes.
20 Jan 2026
PCOS Symptoms and Management: Signs Most Women Overlook
Polycystic Ovary Syndrome (PCOS) is a common hormonal condition affecting millions of women worldwide. Early symptoms are often subtle and overlooked, which can delay diagnosis and treatment.
24 Dec 2025
Patch vs Pills: Why Transdermal Patches Are the Modern Choice for Pain & Wellness
(A Deep Dive into Pain Relief Patches, Wellness Patches & Modern Drug Delivery Technology)
16 Dec 2025
Top 7 Everyday Foods That Trigger Acidity - And How Jeerafast Helps You Enjoy Meals Without the Burn
(A complete Indian-friendly guide for digestion, bloating, acidity, and natural relief)
